Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

PNPLA3 has retinyl-palmit… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

Artikel i vetenskaplig tidskrift
Författare Carlo Pirazzi
L. Valenti
Benedetta Maria Motta
Piero Pingitore
Kristina Hedfalk
Rosellina Margherita Mancina
Maria Antonella Burza
C. Indiveri
Y. Ferro
T. Montalcini
Cristina Maglio
P. Dongiovanni
S. Fargion
R. Rametta
A. Pujia
Linda Andersson
Saswati Ghosal
Malin Levin
Olov Wiklund
M. Iacovino
Jan Borén
Stefano Romeo
Publicerad i Human Molecular Genetics
Volym 23
Nummer/häfte 15
Sidor 4077-4085
ISSN 0964-6906
Publiceringsår 2014
Publicerad vid Institutionen för kemi och molekylärbiologi
Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Sidor 4077-4085
Språk en
Länkar dx.doi.org/10.1093/hmg/ddu121
Ämnesord FATTY LIVER-DISEASE, TRIGLYCERIDE HYDROLASE ACTIVITY, 2ND PRIMARY, TUMORS, HEPATOCELLULAR-CARCINOMA, I148M RS738409, RAT-LIVER, PICHIA-PASTORIS, GENETIC VARIANT, VITAMIN-A, PREVENTION, Biochemistry & Molecular Biology, Genetics & Heredity
Ämneskategorier Klinisk medicin

Sammanfattning

Retinoids are micronutrients that are stored as retinyl esters in the retina and hepatic stellate cells (HSCs). HSCs are key players in fibrogenesis in chronic liver diseases. The enzyme responsible for hydrolysis and release of retinyl esters from HSCs is unknown and the relationship between retinoid metabolism and liver disease remains unclear. We hypothesize that the patatin-like phospholipase domain-containing 3 (PNPLA3) protein is involved in retinol metabolism in HSCs. We tested our hypothesis both in primary human HSCs and in a human cohort of subjects with non-alcoholic fatty liver disease (N = 146). Here we show that PNPLA3 is highly expressed in human HSCs. Its expression is regulated by retinol availability and insulin, and increased PNPLA3 expression results in reduced lipid droplet content. PNPLA3 promotes extracellular release of retinol from HSCs in response to insulin. We also show that purified wild-type PNPLA3 hydrolyzes retinyl palmitate into retinol and palmitic acid. Conversely, this enzymatic activity is markedly reduced with purified PNPLA3 148M, a common mutation robustly associated with liver fibrosis and hepatocellular carcinoma development. We also find the PNPLA3 I148M genotype to be an independent (P = 0.009 in a multivariate analysis) determinant of circulating retinol-binding protein 4, a reliable proxy for retinol levels in humans. This study identifies PNPLA3 as a lipase responsible for retinyl-palmitate hydrolysis in HSCs in humans. Importantly, this indicates a potential novel link between HSCs, retinoid metabolism and PNPLA3 in determining the susceptibility to chronic liver disease.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?